Advanced in Plaque Psoriasis

Dr. Craig Teller

Dermatology
Bellaire Dermatology Associates PA
6565 West Loop S Ste 800, 
Bellaire, TX 
Advanced in Plaque Psoriasis
Bellaire Dermatology Associates PA
6565 West Loop S Ste 800, 
Bellaire, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Teller is a Dermatologist in Bellaire, Texas. Dr. Teller is rated as an Advanced provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Plaque Psoriasis, Intertrigo, Warts, and Seborrheic Keratosis.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 3 clinical trials in the study of Plaque Psoriasis.

Specialties
Dermatology
Licenses
Dermatology in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Bellaire Dermatology Associates PA
6565 West Loop S Ste 800, Bellaire, TX 77401
Call: 713-661-4383

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 10 Less Clinical Trials

14 Total Publications

Aesthetic Improvement With Topical Body Skin Treatment as a Complement to Cryolipolysis.
Aesthetic Improvement With Topical Body Skin Treatment as a Complement to Cryolipolysis.
Journal: Journal of drugs in dermatology : JDD
Published: April 02, 2024
View All 14 Publications
Similar Doctors
Stephen Tyring
Elite in Plaque Psoriasis
Dr. Stephen Tyring
Dermatology
Elite in Plaque Psoriasis
Dr. Stephen Tyring
Dermatology

Houston Skin Cancer Associates PLLC

451 N Texas Ave, 
Webster, TX 
 (23.3 miles away)
281-333-3376
Languages Spoken:
English
See accepted insurances

Stephen Tyring is a Dermatologist in Webster, Texas. Dr. Tyring is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Shingles, Plaque Psoriasis, Psoriasis, and Warts.

Distinguished in Plaque Psoriasis
Dr. Greg Pearson
Dermatology
Distinguished in Plaque Psoriasis
Dr. Greg Pearson
Dermatology

Greg Willaim Pearson MD

915 Gessner Rd Ste 860, 
Houston, TX 
 (5.4 miles away)
713-468-2200
Languages Spoken:
English
See accepted insurances

Greg Pearson is a Dermatologist in Houston, Texas. Dr. Pearson is rated as a Distinguished provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Seborrheic Keratosis, Contact Dermatitis, Warts, and Actinic Keratosis.

Distinguished in Plaque Psoriasis
Dr. Rachel Schmidtberger
Dermatology
Distinguished in Plaque Psoriasis
Dr. Rachel Schmidtberger
Dermatology

Office

21800 Katy Fwy Ste 200, 
Katy, TX 
 (18.7 miles away)
713-771-1100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rachel Schmidtberger is a Dermatologist in Katy, Texas. Dr. Schmidtberger is rated as a Distinguished provider by MediFind in the treatment of Plaque Psoriasis. Her top areas of expertise are Sunburn, Psoriasis, Warts, and Actinic Keratosis.

VIEW MORE PLAQUE PSORIASIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Teller's expertise for a condition
ConditionClose
      • Advanced
      • Actinic Keratosis
        Dr. Teller is
        Advanced
        . Learn about Actinic Keratosis.
        See more Actinic Keratosis experts
      • Familial Atypical Multiple Mole Melanoma Syndrome
        Dr. Teller is
        Advanced
        . Learn about Familial Atypical Multiple Mole Melanoma Syndrome.
        See more Familial Atypical Multiple Mole Melanoma Syndrome experts
      • Giant Congenital Melanocytic Nevus
        Dr. Teller is
        Advanced
        . Learn about Giant Congenital Melanocytic Nevus.
        See more Giant Congenital Melanocytic Nevus experts
      • Giant Congenital Nevus
        Dr. Teller is
        Advanced
        . Learn about Giant Congenital Nevus.
        See more Giant Congenital Nevus experts
      • Intertrigo
        Dr. Teller is
        Advanced
        . Learn about Intertrigo.
        See more Intertrigo experts
      • Neurocutaneous Melanosis
        Dr. Teller is
        Advanced
        . Learn about Neurocutaneous Melanosis.
        See more Neurocutaneous Melanosis experts
      View All 10 Advanced Conditions
      • Experienced
      • Athlete's Foot
        Dr. Teller is
        Experienced
        . Learn about Athlete's Foot.
        See more Athlete's Foot experts
      • Atopic Dermatitis
        Dr. Teller is
        Experienced
        . Learn about Atopic Dermatitis.
        See more Atopic Dermatitis experts
      • Autoerythrocyte Sensitivity
        Dr. Teller is
        Experienced
        . Learn about Autoerythrocyte Sensitivity.
        See more Autoerythrocyte Sensitivity experts
      • Basal Cell Skin Cancer
        Dr. Teller is
        Experienced
        . Learn about Basal Cell Skin Cancer.
        See more Basal Cell Skin Cancer experts
      • Bowen's Disease
        Dr. Teller is
        Experienced
        . Learn about Bowen's Disease.
        See more Bowen's Disease experts
      • Cerebral Cavernous Malformation
        Dr. Teller is
        Experienced
        . Learn about Cerebral Cavernous Malformation.
        See more Cerebral Cavernous Malformation experts
      View All 59 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.